Initial Outcome after Selective Intraarterial Radionuclide Therapy with Yttrium-90 Microspheres as Salvage Therapy for Unresectable Metastatic Liver Disease

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 7, 2013, Pages 534-540

  Turkmen, Cuneyt ^a   Ucar, Adem ^a   Poyanli, Arzu ^a   Vatankulu, Betul ^a   Ozkan, Gozde ^a   Basaran, Mert ^a   Serin, Kursat ^b   Sanli, Yasemin ^a   Adalet, Isik ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

radioembolization; salvage therapy; SIRT; Yttrium 90 microsphere

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MICROSPHERE Y 90; RADIOACTIVE MICROSPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; LIVER FAILURE; LIVER METASTASIS; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RETROSPECTIVE STUDY; SALVAGE THERAPY; TREATMENT RESPONSE; VOMITING;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84881464158     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1455     Document Type: Article

References (33)

1. Sasson AR, Sigurdson ER. Surgical treatment of liver metastases. Semin Oncol 2002;29:107
2. Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Ymicropshere brachytherapy for unresectable colorectal liver metastases: Modern USA experience. Int J Radiat Oncol Biol Phys 2006;65:412
3. Nace GW, Steel JL, Amesur N, et al. Yttrium-90 radioembolization for colorectal cancer liver metastases: A single institution experience. Int J Surg Oncol 2011;2011:1
4. Sato KT, Lewandowski RJ, Mulcahy MF, et al. Unresectable chemorefractory liver metastases: Radioembolization with 90Y microspheres safety, efficacy, and survival. Radiology 2008;247:507
5. Jakobs TF, Hoffmann RT, Dehm K, et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 2008;19:1187
6. Martin LK, Cucci A, Wei L, et al. Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases. Clin Colorectal Cancer 2012;11:195
7. Bester L, Meteling B, Pocock N, et al. Radioembolization versus standard care of hepatic metastases: Comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. J Vasc Interv Radiol 2012;23:96
8. Evans KA, Richardson MG, Pavlakis N, et al. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres. J Vasc Interv Radiol 2010;21:1521
9. Cosimelli M, Golfieri R, Cagol PP, et al. Italian Society of Locoregional Therapies in Oncology (SITILO). Multi-centre phase II clinical trial of yttrium-90 resin microspheres alonein unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer 2010;27;103:324
10. Hoffmann R, Jakobs T, Kubisch C, et al. Radiofrequency ablation after selective internal radiation therapy with yttrium90 microspheres in metastatic liver disease - is it feasible? Eur J Radiol 2010;74:199
11. Van den Eynde M, Flamen P, et al. Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres. Clin Nucl Med 2008;33:697
12. Gulec SA, Pennington K, Hall M, et al. Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: A novel approach to improving the safety of major hepatic resections. World J Surg Oncol 2009;7:6
13. van Hazel G, Blackwell A, Anderson J, et al. Randomised phase II trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004;88:78
14. Sharma RA, Van Hazel GA, Morgan B, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007;25:1099
15. van Hazel GA, Pavlakis N, Goldstein D, et al. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 2009;27:4089
16. Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001;12:1711
17. Gulec SA, Pennington K, Wheeler J, et al. Yttrium-90 Microsphere- selective Internal Radiation Therapy With Chemotherapy (Chemo-SIRT) for Colorectal Cancer Liver Metastases: An in vivo double-arm-controlled phase II trial. Am J Clin Oncol 2012. [Epub ahead of print]. DOI: 10.1097/ COC.0b013e3182546c50
18. Rhee TK, Lewandowski RJ, Liu DM, et al 90Y Radioembolization for metastatic neuroendocrine liver tumours: Preliminary results from a multi-institutional experience. Ann Surg 2008;247:1029
19. King J, Quinn R, Glenn DM, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008;113:921
20. Kennedy AS, Dezarn WA, McNeillie P, et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 2008;31:271
21. Saxena A, Bester L, Chua TC, et al. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: A preliminary assessment of this novel treatment option. Ann Surg Oncol 2010;17:484
22. Ibrahim SM, Mulcahy MF, Lewandowski RJ, et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: Results from a pilot study. Cancer 2008; 113:2119
23. Haug AR, Heinemann V, Bruns CJ, et al 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres. Eur J Nucl Med Mol Imaging 2011;38:1037
24. Hoffmann RT, Paprottka PM, Schon A, et al. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: Factors associated with prolonged survival. Cardiovasc Intervent Radiol 2012;35:105
25. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010;362:1273
26. Dunfee BL, Riaz A, Lewandowski RJ, et al. Yttrium-90 radioembolization for liver malignancies: Prognostic factors associated with survival. J Vasc Interv Radiol 2010; 21:90
27. Zalom M, Yu R, Friedman M, Bresee C, Waxman A. FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease. Clin Nucl Med 2012;37:862
28. Zerizer I, Al-Nahhas A, Towey D, et al. The role of early 18F-FDG PET/CT in prediction of progression-free survival after 90Y radioembolization: Comparison with RECIST and tumour density criteria. Eur J Nucl Med Mol Imaging 2012; 39:1391
29. Gulec SA, Suthar RR, Barot TC, Pennington K. The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy. Eur J Nucl Med Mol Imaging 2011; 38:1289
30. Kucuk ON, Soydal C, Lacin S, et al. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors. World J Surg Oncol 2011;9:86
31. Rafi S, Piduru SM, El-Rayes B, et al. Yttrium-90 Radioembolization for unresectable standard-chemorefractory Intrahepatic Cholangiocarcinoma: Survival, Efficacy, and Safety Study. Cardiovasc Intervent Radiol 2013;36:440
32. Riaz A, Lewandowski RJ, Kulik LM, et al. Complications following radioembolization with yttrium-90 microspheres: A comprehensive literature review. J Vasc Interv Radiol 2009;20:1121
33. Sangro B, Gil-Alzugaray B, Rodriguez J, et al. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors. Cancer 2008;112:1538.